BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9284048)

  • 1. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.
    Funk JO; Waga S; Harry JB; Espling E; Stillman B; Galloway DA
    Genes Dev; 1997 Aug; 11(16):2090-100. PubMed ID: 9284048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.
    Jones DL; Alani RM; Münger K
    Genes Dev; 1997 Aug; 11(16):2101-11. PubMed ID: 9284049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
    Ruesch MN; Laimins LA
    J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
    Luo Y; Hurwitz J; Massagué J
    Nature; 1995 May; 375(6527):159-61. PubMed ID: 7753174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
    Chen J; Jackson PK; Kirschner MW; Dutta A
    Nature; 1995 Mar; 374(6520):386-8. PubMed ID: 7885482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).
    Westbrook TF; Nguyen DX; Thrash BR; McCance DJ
    Mol Cell Biol; 2002 Oct; 22(20):7041-52. PubMed ID: 12242284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.
    Helt AM; Funk JO; Galloway DA
    J Virol; 2002 Oct; 76(20):10559-68. PubMed ID: 12239337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
    Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.
    Albrecht JH; Poon RY; Ahonen CL; Rieland BM; Deng C; Crary GS
    Oncogene; 1998 Apr; 16(16):2141-50. PubMed ID: 9572495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
    Jones DL; Münger K
    J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition.
    Nakanishi M; Robetorye RS; Pereira-Smith OM; Smith JR
    J Biol Chem; 1995 Jul; 270(29):17060-3. PubMed ID: 7615495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early events in DNA replication require cyclin E and are blocked by p21CIP1.
    Jackson PK; Chevalier S; Philippe M; Kirschner MW
    J Cell Biol; 1995 Aug; 130(4):755-69. PubMed ID: 7642695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation and decreased activity of cyclin-dependent kinase 2 in H2O2-induced premature senescence.
    Frippiat C; Remacle J; Toussaint O
    Int J Biochem Cell Biol; 2003 Feb; 35(2):246-54. PubMed ID: 12479875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
    Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
    Medema RH; Klompmaker R; Smits VA; Rijksen G
    Oncogene; 1998 Jan; 16(4):431-41. PubMed ID: 9484832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells.
    Sekiguchi T; Hunter T
    Oncogene; 1998 Jan; 16(3):369-80. PubMed ID: 9467962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amino terminus of Cdk2 binds p21.
    Moskowitz NK; Borao FJ; Dardashti O; Cohen HD; Germino FJ
    Oncol Res; 1996; 8(9):343-52. PubMed ID: 8979268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.